Tilray Brands (TLRY) Inventory (2017 - 2026)
Tilray Brands' (TLRY) quarterly Inventory came in at $301.2 million in Q2 2026, up 11.19% YoY from $270.9 million in Q2 2025, and up 3.04% on a QoQ basis from $292.3 million in Q1 2026.
Tilray Brands (TLRY) Inventory (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Inventory data on file, last reported at $301.2 million in Q2 2026.
- Quarterly Inventory rose 11.19% year-over-year to $301.2 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $301.2 million (up 11.19% YoY) and the FY2026 annual result came in at $301.2 million, up 11.19% from the prior year.
- Inventory improved to $301.2 million in Q2 2026, from $292.3 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $301.2 million in Q2 2026 to a low of $200.6 million in Q2 2023.
- A 5-year average of $256.3 million and a median of $258.0 million in 2023 frame the typical range for Inventory.
- Annual changes were most pronounced in 2023 — Inventory dropped 25.79% — and 2024, when it climbed 25.7%.
- Tracing TLRY's Inventory over 5 years: stood at $240.9 million in 2022, then grew by 4.88% to $252.7 million in 2023, then increased by 5.27% to $266.0 million in 2024, then advanced by 6.46% to $283.2 million in 2025, then climbed by 6.35% to $301.2 million in 2026.
- The last three Inventory figures came in at $301.2 million (Q2 2026), $292.3 million (Q1 2026), and $283.2 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 816.00 Mn |
| 10 | Tilray Brands | 512.61 Mn | 277.98 Mn | 90.52 Mn | 301.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 301.19 Mn |
| Feb 28, 2026 | 292.30 Mn |
| Nov 30, 2025 | 283.20 Mn |
| Aug 31, 2025 | 282.79 Mn |
| May 31, 2025 | 270.88 Mn |
| Feb 28, 2025 | 263.40 Mn |
| Nov 30, 2024 | 266.01 Mn |
| Aug 31, 2024 | 264.30 Mn |
| May 31, 2024 | 252.09 Mn |
| Feb 29, 2024 | 244.14 Mn |
| Nov 30, 2023 | 252.70 Mn |
| Aug 31, 2023 | 232.08 Mn |
| May 31, 2023 | 200.55 Mn |
| Feb 28, 2023 | 202.80 Mn |
| Nov 30, 2022 | 240.95 Mn |
| Aug 31, 2022 | 244.65 Mn |
| May 31, 2022 | 245.53 Mn |
| Feb 28, 2022 | 273.29 Mn |
| Nov 30, 2021 | 233.02 Mn |
| Aug 31, 2021 | 251.51 Mn |